Barinthus Biotherapeutics PLC
BRNS0.739USD
+0.008+1.04%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
30.17MMarket Cap
LossP/E TTM
Barinthus Biotherapeutics PLC Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
14.97M
1766.46%
EPS(YoY)
-1.55
18.77%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Barinthus Biotherapeutics PLC?
According to Barinthus Biotherapeutics PLC's FY2024 earnings report, its total revenue reached 14.97M, with a year-on-year change of 1766.46%.
What is the Earnings Per Share (EPS) of Barinthus Biotherapeutics PLC?
According to Barinthus Biotherapeutics PLC's FY2024 earnings report, its Earnings Per Share (EPS) was -1.552, with a year-on-year change of 18.77%.
What is the net income of Barinthus Biotherapeutics PLC?
According to Barinthus Biotherapeutics PLC's FY2024 earnings report, its net income was -61.07M, with a year-on-year change of 16.73%.
What is the net margin of Barinthus Biotherapeutics PLC?
According to Barinthus Biotherapeutics PLC's FY2024 earnings report, its net profit margin was -408.73%, with a year-on-year change of 95.54%.
What is the gross margin of Barinthus Biotherapeutics PLC?
According to Barinthus Biotherapeutics PLC's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Barinthus Biotherapeutics PLC?
According to Barinthus Biotherapeutics PLC's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Barinthus Biotherapeutics PLC?
According to Barinthus Biotherapeutics PLC's FY2024 earnings report, its Return on Equity (ROE) was -38.56%, with a year-on-year change of -12.93%.
What is the Return on Assets (ROA) of Barinthus Biotherapeutics PLC?
According to Barinthus Biotherapeutics PLC's FY2024 earnings report, its Return on Assets (ROA) was -32.65%, with a year-on-year change of -7.72%.
What is the operating profit of Barinthus Biotherapeutics PLC?
According to Barinthus Biotherapeutics PLC's FY2024 earnings report, its operating profit was -50.46M, with a year-on-year change of 39.87%.
What are the current assets of Barinthus Biotherapeutics PLC?
According to Barinthus Biotherapeutics PLC's FY2024 earnings report, its current assets were 125.74M, with a year-on-year change of -19.86%.
What are the total assets of Barinthus Biotherapeutics PLC?
According to Barinthus Biotherapeutics PLC's FY2024 earnings report, its total assets of Barinthus Biotherapeutics PLC were 160.33M, with a year-on-year change of -25.26%.
What are the total liabilities of Barinthus Biotherapeutics PLC?
According to Barinthus Biotherapeutics PLC's FY2024 earnings report, its total liabilities of Barinthus Biotherapeutics PLC were 30.19M, with a year-on-year change of 9.75%.
What is the total equity of Barinthus Biotherapeutics PLC?
According to Barinthus Biotherapeutics PLC's FY2024 earnings report, its total equity of Barinthus Biotherapeutics PLC was 130.13M, with a year-on-year change of -30.41%.
What is the net operating income of Barinthus Biotherapeutics PLC?
According to Barinthus Biotherapeutics PLC's FY2024 earnings report, its net operating income of Barinthus Biotherapeutics PLC was -61.18M, with a year-on-year change of 16.70%.
What is the net investment of Barinthus Biotherapeutics PLC?
According to Barinthus Biotherapeutics PLC's FY2024 earnings report, its net investment of Barinthus Biotherapeutics PLC was -892.00K, with a year-on-year change of 83.52%.
What is the net financing of Barinthus Biotherapeutics PLC?
According to Barinthus Biotherapeutics PLC's FY2024 earnings report, its net financing of Barinthus Biotherapeutics PLC was 2.16M, with a year-on-year change of 15.54%.
